70
Participants
Start Date
March 1, 2021
Primary Completion Date
April 1, 2021
Study Completion Date
May 15, 2021
Clinical and biological characteristics
"* Age at beginning of IOT~* Sex~* Atopic and non atopic Comorbidities~* Sensitization to aero-allergens~* Sensitization to trophallergens~* Stage of severity of the elicited reaction~* Hazelnut Specific IgE + Cor a 1,8,9,14 before IOT and during follow up~* Hazelnut skin prick test before IOT and during follow up~* Adverse effects of IOT and their stage (in hospital and at home)~* Use of adrenaline auto-injector (in hospital and at home)~* Maintenance dose"
Pneumology allergology-paediatric department of the Mother and Child Hospital, Bron
Hospices Civils de Lyon
OTHER